drugset / Trial / NCT05251376
Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
NaSingle-groupOpen-labelTreatment
Summary
A Phase 1, Single Dose, Open-label, Safety, Tolerability, and Pharmacokinetic Study of LYN-014 in Individuals with Opioid Use Disorder Who are Stable on Methadone Therapy
Timeline
- Start
- 2022-02-28
- Primary completion
- 2022-12-19
- Completion
- 2022-12-19
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levomethadone | Small molecule | 187 mg | Oral |
| Background | Methadone | Other / unclassified | — | Oral |
| Background | Morphine | Other / unclassified | — | — |